-
ABOUT US
-
R&D
-
AGORA
-
PR
-
RECRUITMENT
-
CONTACT
ABOUT US
ABOUT US
Leadership
Leadership
-
Moonkyung Choe, CEO
View more -
Hyung-Ji Kim, Co-CEO
View more -
Hyo Joon Kim, COO
View more -
Jae Kyoung Choi, CFO
View more -
Hyun Ryoung Kim, CTO
View more -
Bert Binas, CSO
View more -
Min Jae Kim, CDO
View more -
Munsik Seol
AuditorView more
Advisory Group
-
Henry M. Kaiser
View more -
David Arthur Berry
View more -
Arthur Paul Becker
View more -
Ryan Chin
View more -
Chong Sam Chi
View more -
Craig Reinemeyer
View more -
Yoon-Cheol Koo
View more
Moonkyung Choe, Ph.D.
CEO
Moonkyung Choe, Ph.D., CEO of 3H Bio Co., Ltd., Korea.
She received her Ph.D. degree from the College of Science and Convergence Technology, Hanyang University in Korea, and was trained as a researcher in Postech and Gachon University, Korea.
Hyung-Ji Kim
Co-CEO
Hyung-Ji Kim, M.D., Ph.D., is Co-CEO of 3H Bio Co., Ltd., Korea, and an Assistant Professor at the Department of Neurology, Eulji University School of Medicine.
He received his Ph.D. degree from the College of Medicine, University of Ulsan, and was trained as a dementia specialist at Asan Medical Center, Seoul, Korea.
Hyo Joon Kim, Ph.D.
COO
Hyo Joon Kim, Ph.D., COO of 3H Bio Co., Ltd., Korea, is an Emeritus Professor at the Division of
Molecular and Life Science, Hanyang University.
He received his Ph.D. degree from the College of Pharmacy, Osaka University in Japan, and was trained as a Post Doc in the Center for Cancer Research at MIT, USA.
His scientific research on obesity immunotherapeutics has been supported by successive
grants from the Ministry of Sciences and Technology,
the Ministry of Knowledge and Economy,
and the Ministry of Education, Science and Technology of Korea.
Jae Kyoung Choi, MBA
CFO
Mr. Choi, Jae Kyoung is the co-founder and CFO of 3H Bio.
He has been working as company builder and venture capitalist since 1997.
He has rich experience in company building and venture capital from co-founding to IPO and M&A.
He was the co-founder and CEO of I-Venture Capital and Managing Director of Investment in Actnerlab.
He got an MBA degree from the University of Sydney and the University of Texas at Austin.
Hyun Ryoung Kim, Ph.D.
CTO
Hyun Ryoung Kim, Ph.D., is the CTO of 3H Bio Co., Ltd., Korea.
She graduated from the University of Paris XI with a Ph.D. in pharmacy.
She worked then at the Samsung Advanced Institute of Technology as a project leader in the drug formulation research group, and at Daewoong Pharmaceuticals as a team leader in the New Product R&D Center.
Subsequently, she worked as CTO at IMGT, a Korean biotech company.
She has 17 years of professional experience in CMC.
Bert Binas, Ph.D.
CSO
Bert Binas, Ph. D., CSO of 3H Bio Co., Ltd., Korea.
He has a professional background in lipid metabolism and stem cell biology.
He received his doctorate in Cellular Biochemistry at the Central Institute for Molecular Biology (Germany), and postdoctoral training at the Roslin Institute (U. K.) and the Max Delbrueck Center for Molecular Medicine (Germany).
He was then an Associate Professor at Texas A&M University (USA) and a - now retired - Full Professor at Hanyang University (Korea).
Min Jae Kim, Ph.D.
CDO
Min Jae Kim, Ph.D., CDO of 3H Bio Co., Ltd., Korea.
He received his Ph.D. degree from the College of Science and Convergence Technology,
Hanyang University in Korea, and was trained as Post Doc in the same place.
Munsik Seol
Auditor
Munsik Seol is serving as an Auditor at 3H Bio Co., Ltd.
He graduated from Seoul National University with a bachelor's degree in Economics.
He worked in finance and budget for more than 30 years in the Ministry of Finance, Budget Administration, Presidential Office, Ministry of Economy and Finance in Korea government.
He was Vice Governor of Economic Affairs in Chungcheongbuk-Do Province from 2012 to 2017.
He also served as Chairman of the Board of Chungcheong University from 2021 to February 2023.
Additionally, he serves as an advisor to the global e-commerce company, Alibaba.com, Singapore E-Commerce Private Limited.
Henry M. Kaiser, Psy.D., MBA
Advisor
Henry M. Kaiser, Psy.D., MBA, is an Advisor for 3H Bio Co., Ltd.
He got an MBA degree from the Stanford University Graduate School of Business, and a Psy.D.
degree from Meridian University. He is Chairman Emeritus of Thomsen’s Inc.
He has served in numerous leadership roles on Portfolio Company Boards and community and arts organizations.
He previously served on the National Board of Kaiser Foundation Hospitals & Health Plan and as a Trustee of the Kaiser Family Foundation and was a Director of the Kaiser Foundation Hospitals & Health Plan and a Trustee of Kaiser Family Foundation.
He briefly served in a management role as President of Kaiser Foundation International.
David Arthur Berry, M.D., Ph.D.
Advisor
David Arthur Berry, M.D., Ph.D., is an Advisor for 3H Bio Co., Ltd.
He got an M.D. degree from Harvard Medical School and a Ph.D. degree from the Massachusetts Institute of Technology.
He has co-founded more than 25 companies, including Seres Therapeutics, Indigo Agriculture, and Axcella Health.
He previously served as Founder and CEO of Valo Health, as general partner at Flagship Pioneering, and is now running with his brother Bedford Bridge, a $300 million health tech and longevity VC firm.
He is also an early founding developer of Moderna.
Arthur Paul Becker
Advisor
Arthur Paul Becker is an Advisor for 3H Bio Co., Ltd.
He is the current CEO of Oncopep, a cancer vaccine company.
He is a Venture Partner with CoBro Ventures and is on the Boards of NextRNA, AI Proteins, and OncoPep.
He is also a Managing Member of Madison Technology, LLC, an investment firm.
He was formerly the Chairman & CEO of Zinio, LLC, the world’s largest digital newsstand.
Ryan Chin
Advisor
Ryan Chin is an Advisor for 3H Bio Co., Ltd.
He is CEO & Managing General Partner at Black Kestral Group, a Private Investment Office & Consultancy (Singapore family office).
Black Kestral Group is a member of Xen Capital Pte. Ltd.
Chong Sam Chi
Advisor
Chong Sam Chi is an Advisor for 3H Bio Co., Ltd.
He is the CEO of Trident Global Holdings & Trident Investment Holdings.
He served as Vice President of JP Morgan from 1998 to 2002.
Craig Reinemeyer
Advisor
Craig Reinemeyer is an Advisor for 3H Bio Co., Ltd.
He got a DVM degree from the Ohio State University College of Veterinary Medicine.
He founded East Tennessee Clinical Research, Inc.,
where he has been continuously serving as President and Scientific Officer.
This company runs one of the few labs capable of carrying out clinical drug testing to meet FDA standards for large animals and companion animals.
Accordingly, East Tennessee Clinical Research, Inc.
has been instrumental in bringing several new products to the market.
Yoon-Cheol Koo
Advisor
Yoon-Cheol Koo is an Advisor for 3H Bio Co., Ltd.
He graduated from Seoul National University.
He got a master's degree from Seoul National University's Graduate School of Public Administration and a master's degree in Public Policy from the University of Wisconsin-Madison.
He served as the Second Vice Minister of Economy and Finance from 2018 to 2020, and the Director of the Office for Government Policy Coordination from 2020 to 2022.
He is currently a specially appointed professor in the Department of Economics at Seoul National University.